Zydus Defeats 209-Patient Suit Over Heart Pill Marketing
Zydus Pharmaceuticals USA Inc. shed claims by 209 people alleging they or their loved ones were harmed by the off-label marketing of a generic heart medication, with a New Jersey federal...To view the full article, register now.
Already a subscriber? Click here to view full article